Svexa's Dr Filip Larsen starting new overtraining study - G.L.I.M.P.S.E

Many members of the Svexa team are leading scientific research worldwide into the subjects around elite athlete performance and physiology. Our Chief Science Officer Filip Larsen has recently received funding for his latest project - GLIMPSE. The study will use data science to understand the connection between GLucose metabolism, Immune function, Mitochondria, Performance and Sleep in Elite athletes.

It is well established that an appropriate level of exercise improves performance, whereas too much training leads to staleness and reduced performance. At the same time, athletes are advised to get more sleep time and improve the quality of sleep to improve recovery. These are related - moderate levels of exercise increase sleep quality while excessive exercise can cause sleep disturbance.

The GLIMPSE study will follow elite athletes in their normal training and competitions for one year, using the latest technology to track blood glucose, sleep pattern, training load, subjective well-being and athletic performance continuously with minimal interference. With this data, Filip and his team will demonstrate how blood glucose levels affect sleep patterns in elite athletes, use this monitoring to detect early signs of overtraining, and ultimately predict athletic performance by tracking training volume/intensity, nocturnal blood glucose, sleep patterns, immune function and mood state.

As well as being Chief Science Officer for Svexa, Filip is PhD, Associate Professor of Exercise Physiology at the Swedish School of Sports & Health Sciences. He specializes in mitochondrial physiology in relation to overtraining and training optimization, nutrition. Filip is also Physiologist for the Swedish National Orienteering Team, and a keen athlete himself.